Prevalence of Hypothyroidism in Peri-/Post-Menopausal Thai Women
Article Sidebar
Main Article Content
Abstract
Objectives: This study aimed to determine the prevalence of hypothyroidism and its association with menopausal symptoms and evaluated the diagnostic performance of Zulewski’s clinical score for predicting hypothyroidism in peri-/post-menopausal Thai women.
Materials and Methods: This hospital-based cross-sectional study was conducted between June 2015 and April 2016 in Srinagarind Hospital, Khon Kaen, Thailand. We enrolled 305 peri-/post- menopausal women 45-65 years of age without previous history of thyroid diseases, radiation exposure at the neck, or concurrent use of lithium. The participants were interviewed by two research assistants’ vis-à-vis symptoms of menopause and hypothyroidism, current medications and menstrual characteristics. Blood samples were taken for TSH and FT4 levels. Main outcomes were prevalence of hypothyroidism, the Menopause-Specific Quality of Life (MENQOL) score, and diagnostic performance of Zulewski’s clinical score .
Results: Mean age was 56 ± 4.7 years. The prevalence of hypothyroidism was 6.2% (95%CI 3.5% to 8.9%). The sensitivity of Zulewski’s clinical score at the cutoff point ≥ 3 was 70%. Neither the MENQOL domain score nor the composite score was associated with hypothyroidism.
Conclusion: The prevalence of hypothyroidism in peri-/post-menopausal Thai women is low. There is no association between MENQOL score and hypothyroidism. Zulewski’s clinical score is not a good screening test for hypothyroidism in this group.
Keywords: menopausal women, hypothyroidism, Zulewski’s clinical score, MENQOL
Article Details
References
2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34.
3. Vanderpump MP, Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002;12:839-47.
4. Sowers M, Luborsky J, Perdue C, Araujo KL, Goldman MB, Harlow SD. Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN. Clin Endocrinol (Oxf) 2003;58:340-7.
5. Massoudi MS, Meilahn EN, Orchard TJ, Foley TP, Jr., Kuller LH, Costantino JP, et al. Thyroid function and perimenopausal lipid and weight changes: the Thyroid Study in Healthy Women (TSH-W). J Womens Health 1997;6:553-8.
6. Schindler AE. Thyroid function and postmenopause. Gynecol Endocrinol 2003;17:79-85.
7. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010;304:1365-74.
8. Zimmermann MB, Andersson M. Assessment of iodine nutrition in populations: past, present, and future. Nutr Rev 2012;70:553-70.
9. Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trends over the past decade. J Nutr 2012;142:744-50.
10. World Health Organization (WHO). Iodine and Health: Eliminating Iodine Deficiency Disorders Safely throughSalt Iodization. Geneva, Switzerland: World Health Organization 1994.
11. Zhao W, Han C, Shi X, Xiong C, Sun J, Shan Z, et al. Prevalence of goiter and thyroid nodules before and after implementation of the universal salt iodization program in mainland China from 1985 to 2014: a systematic review and meta-analysis. PLoS One 2014;9:e109549.
12. Hilditch JR, Lewis J, Peter A, van MB, Ross A, Franssen E, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161-75.
13. Pongpatiroj A, Sripramote M, Wanitwanathong G. Effects of hormone replacement therapy on the quality of life in postmenopausal women. Vajira Med J 2001;45:1-11.
14. Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997;82:771-6.
15. Suchartwatnachai C, Thepppisai U, Jirapinyo M. Screening for hypothyroidism at a menopause clinic. Int J Gynaecol Obstet 2002;77:39-40.
16. WHO Expert Consultant. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63.
17. Garin MC, Arnold AM, Lee JS, Tracy RP, Cappola AR. Subclinical hypothyroidism, weight change, and body composition in the elderly: the Cardiovascular Health Study. J Clin Endocrinol Metab 2014;99:1220-6.
18. Sakurai M, Nakamura K, Miura K, Yoshita K, Takamura T, Nagasawa SY, et al. Association between a serum thyroid-stimulating hormone concentration within the normal range and indices of obesity in Japanese men and women. Intern Med 2014;53:669-74.
19) Solanki A, Bansal S, Jindal S, Saxena V, Shukla US. Relationship of serum thyroid stimulating hormone with body mass index in healthy adults. Indian J Endocrinol Metab 2013;17(Suppl 1):S167-S169.
(20) Bjergved L, Jorgensen T, Perrild H, Laurberg P, Krejbjerg A, Ovesen L, et al. Thyroid function and body weight: a community-based longitudinal study. PLoS One 2014;9:e93515.
21. Fox CS, Pencina MJ, D’Agostino RB, Murabito JM, Seely EW, Pearce EN, et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med 2008;168:587-92.
22. Svare A, Nilsen TI, Bjoro T, Asvold BO, Langhammer A. Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway. Clin Endocrinol (Oxf) 2011;74:769-75.
23. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012;18:988-1028.
24. Li H, Yuan X, Liu L, Zhou J, Li C, Yang P, et al. Clinical evaluation of various thyroid hormones on thyroid function. Int J Endocrinol 2014;2014:618572.